An investigation into the use of bilirubin oxidase to measure the apparent concentration of unbound bilirubin in solutions of bilirubin or bilirubin/human serum albumin demonstrated (1) near linearity of oxidation rate with bilirubin concentration up to 16 μmol/L, (2) linearity with respect to enzyme concentration up to 75 mg/L, (3) specificity of the enzyme for unbound bilirubin, as opposed to bound bilirubin, (4) poor precision. Very small absorbance changes leading to poor precision and the potential for interference by conjugated bilirubin meant that the method was unsuitable for patient samples.
References
1.
IsherwoodDMFletcherKA. Neonatal jaundice: investigation and monitoring. Ann Clin Biochem1985; 22: 109–28.
2.
KapitulnikJBondheimSHKaufmannNA. Sephadex adsorption of bilirubin from neonatal and adult serum. Clin Chem1972; 18: 43–7.
3.
JacobsenJWennbergRP. Determination of unbound bilirubin in the serum of newborns. Clin Chem1974; 20: 783–9.
4.
NakamuraHLeeY. Microdetermination of unbound bilirubin in icteric newborn sera: an enzymatic method employing peroxidase and glucose oxidase. Clin Chim Acta1977; 79: 411–7.
5.
MaguireGA. Elimination of the ‘Chromogen oxidase’ activity of bilirubin oxidase added to obviate bilirubin inteference in hydrogen peroxide/peroxidase detecting systems. Clin Chem1985; 31: 2007–8.
6.
AhlforsCE. Effect of serum dilution on apparent unbound bilirubin concentration as measured by the peroxidase method. Clin Chem1981; 27: 692–6.
